November, 2024
According to the World Cancer Research Fund International, the maximum cases of breast cancer were found in China (357,161) in 2022, followed by the U.S. (274,475) and India (192,020). There is both a rising prevalence and rising awareness of breast cancer worldwide. This is spurring growth in the chemotherapy market, which deals in developing therapeutics for treating various types of cancers. The different drugs manufactured by this industry include alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, and others. There are also several government initiatives in the space, with several governments pledging investments. In August 2024, the U.S. government announced a US$400 million investment to enhance cancer treatment facilities in this region. The growing demand for oncology drugs worldwide has boosted the market growth.
This market is driven by rising investment in cancer research and treatment by several organizations. The growing incidence of breast cancer worldwide is also propelling the growth of the chemotherapy market. Rising advancement in magnetic hyperthermia-based cancer therapy and antibody-drug conjugates (ADCs) will create opportunities for market players in the coming years. In August 2024, Lupin launched the Doxorubicin Hydrochloride Liposome injection. The drug was developed to treat ovarian cancer in the U.S.
This market comprises several players such as Sanofi, Novartis, Pfizer Inc., GlaxoSmithKline, and others. Sanofi SA is one of the leading companies in this industry that received a payment of US$ 100 million in November 2022 for LIBTAYO, a chemotherapy drug. Pfizer is another prominent market player that generated revenue of US$ 57,186 million from the biopharmaceutical segment, including the oncology division.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form
URL TO BE USED AS REFERENCE LINK:
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the first item's
accordion body.
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the second item's
accordion body. Let's imagine this being filled with some actual content.
Placeholder content for this accordion, which is intended to demonstrate the .accordion-flush class. This is the third
item's accordion body. Nothing more exciting happening here in terms of content, but just filling up the space to make it look, at least at
first glance, a bit more representative of how this would look in a real-world application.
Do you still any question?
Feel free to contact us anytime using our contact form or visit our FAQ page.
Your contact to the Infographics Newsroom
